IASO General Clinic: Τhe first Hybrid Center for the Treatment of Urolithiasis in Greece

IASO General Clinic: Τhe first Hybrid Center for the Treatment of Urolithiasis in Greece

IASO General Clinic has in its possession the latest generation Extracorporeal Lithotripter Modulith SLX F2 CONNECT. It is the most advanced Extracorporeal Shock Wave Lithotripsy (ESWL) system worldwide and the only one in Greece. It is the flagship of the Extracorporeal Shock Wave Lithotripsy Unit, as it has comparative advantages over obsolete machines.

IASO General Clinic has created a state-of-the-art hybrid center for the treatment of urolithiasis in a specially designed space, which incorporates all the modern trends in urology. The center is staffed with specialized medical and nursing personnel, providing even complete treatment of lithiasis, both in terms of prevention, diagnosis and monitoring, as well as treatment of the disease.

This system, depending on the selected imaging mode and the adjustable patient height, automatically defines the exposure and imaging parameters, as well as the field of the ionization chamber. The focal point, the voltage and current of the X-ray tube are selected by the system in such a way as to minimize the risk of radiation exposure to the patient and personnel. Very importantly, it does not cause any damage to nearby organs.

DICOM images can be received and delivered to the patient, in excellent quality. It stores images by sending them to a PACS system (patient record). It has a C-arm flat-panel with comparative advantages over all the other systems. The focus size can be selected between 3 sizes and lithotripsy is possible throughout the entirety of the urinary tract.

The unique rotation facility of the stationary X-ray system creates sufficient working space above the patient, an unlimited field of view and free access to the table. This means that the MODULITH SLX F2 CONNECT with its integrated lithotripter is the only system on the market that meets all the demands of a modern, urological X-ray workstation.

The system has a unique pediatric program for treating children. With this program, an additional radiation filter is activated. It has preset image acquisition settings for optimal imaging within the framework of the intended use for extracorporeal lithotripsy, for endourological procedures such as ureterolithotripsy – nephrolithotripsy – percutaneous nephrolithotripsy. Stent placement - removal - cystoscopy – TURP, TURB, urography are carried out. The lithotripsy results are impressive, due to the advanced, latest-generation shockwave ultrasound technology, combined with the large focal depth and large head surface.


For more journalistic information: Nancy Christopoulou, IASO Group Commercial & Marketing Department, tel.:  210 6383917, E-mail: [email protected]

    View also:

    IASO General Clinic: Exclusive Check-Up Packages for Breast Cancer on the occasion of Breast Cancer Awareness Month
    GENERAL

    IASO General Clinic: Exclusive Check-Up Packages for Breast Cancer on the occasion of Breast Cancer Awareness Month

    On the occasion of Breast Cancer Awareness Month, IASO General Clinic is actively participating in the effort to raise awareness and promot...

    IASO General Clinic:One-Day Conference on “Infections in Obstetrics and Gynecology”
    GENERAL

    IASO General Clinic:One-Day Conference on “Infections in Obstetrics and Gynecology”

    IASO General Clinic in collaboration with the Internal Medicine - Infectious Diseases Clinic is organizing a One-Day Conference on the topic: “Infections in Obstetrics and Gynecology”, which will be held on Saturday, October 11th, 2025, at 09:00, at IASO Hospital’s Event Hall (37-39 Kifissias Ave, Maroussi). The aim of the Conference is to highlight the importance of early diagnosis and p...

    IASO General Clinic: Robotic mastectomy and reconstruction
    GENERAL

    IASO General Clinic: Robotic mastectomy and reconstruction

    A pioneering Robotic double Mastectomy and Reconstruction was successfully performed at IASO General Clinic on a 42-year-old woman who is a carrier of the BRCA1 gene, which is responsible for hereditary breast cancer, with the use of...